Skip to Content

HCA Healthcare West Florida provides monoclonal antibody therapy at four hospitals

Supporting communities from Charlotte County to Citrus County.

December 10, 2020
St. Petersburg General Hospital’s Kandice Williams, RN (right) and Vinson Huynh, M.D. (left) successfully performed HCA Healthcare West Florida’s first Monoclonal Antibody Therapy on patient Harry (center) on Wednesday.
Supporting communities from Charlotte County to Citrus County.

Tampa, FL — HCA West Florida is now offering Bamlanivimab antibody infusions at four hospitals to non-hospitalized patients who have tested positive for COVID-19 and have other high-risk factors. Participating hospitals include Blake Medical Center in Manatee County, Brandon Regional Hospital in Hillsborough County, St. Petersburg General Hospital in Pinellas County, and Medical Center of Trinity in Pasco County.

The U.S. Food & Drug Administration (FDA) granted Emergency Authorized Use (EUA) of Bamlanivimab for the treatment of COVID-19 patients experiencing mild to moderate symptoms who are high risk to develop severe COVID-19. All four hospitals will provide the outpatient IV treatment for adults and Brandon Regional Hospital will also provide the treatment for adolescents age 12 and older.

High-risk conditions that may be eligible for this treatment include:

  • Obesity
  • Chronic kidney disease
  • COPD
  • Diabetes
  • Immunosuppressive disease
  • Heart disease

For children over the age of 12, sickle cell disease, neurodevelopmental disorders, and asthma are also among several additional considerations for eligibility.

“We’re committed to providing our patients, caregivers, and the communities we serve with the latest treatments in the fight against COVID-19 and are excited to bring this option to our four different geographic areas along Florida’s west coast,” said Dr. Larry Feinman, Chief Medical Officer for HCA Healthcare West Florida. “The four locations will support all of our local hospitals in working closely with physicians and other providers across the communities we serve to provide treatment to patients who may benefit, per FDA guidelines.”

The medication supply is limited and based on availability. Patients will need a physician referral and meet FDA criteria prior to scheduling. The treatment is a one-time intravenous infusion over the course of one hour followed by an hour of monitoring. Scheduling for patients who meet the criteria can be made by calling: Blake Medical Center at (941) 798-6150, Brandon Regional Hospital at (813) 916-1581 or (813) 460-3187, Medical Center of Trinity at (727) 834-4917 and St. Petersburg General Hospital at (727) 341-4909.

Bamlanivimab is not authorized for use for patients who:

  • Are hospitalized due to COVID-19
  • Require oxygen therapy due to COVID-19
  • Require oxygen due to another underlying medical condition

For more information on monoclonal antibody treatment for COVID-19, visit the Coronavirus Research Hub at HCA Healthcare.

December 10, 2020
HCA Florida Healthcare